Phase of Trial: Phase I/II
Latest Information Update: 24 May 2010
At a glance
- Drugs Reximmune C; Rexin-G
- Indications Advanced breast cancer
- Focus Adverse reactions; Pharmacodynamics
- Acronyms GeneVieve
- Sponsors Epeius Biotechnologies Corporation
- 24 May 2010 Trial acronym added.
- 24 May 2010 Interim results will be presented at ASCO on June 6 2010, according to a Epeius Biotechnologies Corporation media release
- 05 Jul 2006 New trial record.